Testosterone substitution in male hypogonadism is a recognized tool to treat symptomatic patients. Various forms of this treatment exist including a long-acting intramuscular form using testosterone ...
Credit: Thinkstock. The risk of hematocrit elevation may depend on testosterone therapy's route of administration, according to investigators. A rise in hematocrit levels occurs with 4 months of ...
WOBURN, Mass., Dec. 12, 2024 /PRNewswire/ -- Azurity Pharmaceuticals announced today the availability of Azmiro™, the first and only FDA-approved prefilled testosterone cypionate injection. Azmiro is ...
Intramuscular injection of testerosterone replacement therapy confers greater health benefits and lower cardiovascular risks than transdermal administration by skin patch or gel, a new study concludes ...
The Food and Drug Administration (FDA) has, for the third time, declined approval of the long-acting testosterone undecanoate injection product (Aveed, Endo Pharma Solutions) for the treatment of men ...
This international, prospective, observational study followed 1,438 hypogonadal men who received up to five long-acting intramuscular testosterone undecanoate injections over 9–12 months. Improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback